1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Asset Management
Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc.

KBPH
Kyto Technology and Life Science, Inc.US flagOther OTC
1.00
USD
-0.84
- -
13.29MMarket Cap
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.5
-0.46
-0.4
-0.17
-0.21
-0.09
-6.16
-0.03
-0.03
-0.03
-0.04
-0.13
0.06
0.08
Free Cash Flow per Basic Share
-0.46
-0.41
-0.19
-0.07
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.04
-0.33
-0.36
-0.31
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-12.93
-13.39
-13.53
-13.7
-13.91
-13.99
-14.22
-10.25
-10.28
-10.31
-5.58
-5.71
-4.83
-2.4
Tangible Book Value per Share
-0.78
-1.25
-1.43
-1.55
-0.56
-0.65
-0.02
-0.04
-0.07
-0.1
0.26
0.45
1.02
0.96
Basic Weighted Avg Shares
1
1
1
1
1
1
2
3
3
3
6
6
7
13
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2,556.47
-4,696.3
- -
255,685.54
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
- -
- -
- -
- -
-14
- -
- -
- -
- -
-1
- -
1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2,556.74
-5,465.72
- -
-224,614.85
Working Capital
-1
-1
-1
-2
- -
- -
- -
- -
- -
- -
- -
- -
1
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-1
-1
-2
- -
- -
- -
- -
- -
- -
2
3
7
13
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-11.25
-13.37
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1.29
-3.51
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
18
23
27

Working Capital

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-14.98%
-49.88%
162.15%
Free Cash Flow
146.96%
288.24%
28.02%
Net Income, GAAP
1,563.31%
46.97%
-155.22%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.03
-0.02
-0.02
- -
-0.13
2021
-0.01
0.05
- -
- -
0.06
2022
-0.03
0.08
0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Paul M. Russo
Full Time Employees
1
Sector
Financial Services
Industry
Asset Management
Address
13050 La Paloma Road Los Altos Hills CA United States of America 94022
IPO Date
May 1, 2007
CIK
0001164888
Website
kytotech.com
Similar Companies
Baillie Gifford China Growth Trust PLC (BGCG.L)
Aurora Investment Trust plc (ARR.L)
Formuepleje Mix High (FPIMHI.CO)
Third Avenue Small-Cap Value Fund Insti Class (TASCX)
UBS IQ MSCI Australia Ethical ETF (UBA.AX)
Insignia Financial Ltd. (IOOFF)
Business
Kyto Technology and Life Science, Inc. functions as a venture capital entity focused on emerging and early-stage enterprises. The firm structures its capital injections through secured convertible debt, which accrues interest and provides a conversion discount into preferred shares, or by direct acquisition of preferred shares. Its primary investment focus lies within the technology and life science sectors. This organization typically does not initiate financing rounds but rather participates alongside other investors. Kyto Technology and Life Science, Inc. allocates more than half of its investments within the United States, with the remaining capital deployed across Canada and Israel. The firm employs a rigorous vetting process, often following the lead of established angel investor groups while conducting its own extensive due diligence. Furthermore, it actively supports its portfolio companies by serving as an advisor, mentor, and often securing board or observer positions. The company, originally established as Kyto BioPharma, Inc., adopted its current name in April 2018. Founded in 1999, Kyto Technology and Life Science, Inc. maintains its headquarters in Los Altos Hills, California, complemented by an additional facility in Scotts Valley, California.